INMUNE BIO INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
INMUNE BIO INC. (INMB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.14 million shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-10-30
- INMUNE BIO INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 11.25M shares, a 102.97% increase year-over-year.
- INMUNE BIO INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 5.54M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2025-09-30 | 11.14M shares 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | 11.23M shares 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | 11.25M shares 10-Q · filed 2025-05-08 | ||
| 2024-09-30 | 10.24M shares 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | 7.89M shares 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 5.54M shares 10-Q · filed 2025-05-08 | ||
| 2023-09-30 | 5.58M shares 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | 5.58M shares 10-Q · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |